The DOI matches its Crossref record; 40 of the 42 references it cites were found in a registry or an index.
DNA Damage-Mediated Induction of a Chemoresistant Niche
Open accessAbstract
While numerous cell-intrinsic processes are known to play decisive roles in chemotherapeutic response, relatively little is known about the impact of the tumor microenvironment on therapeutic outcome. Here, we use a well-established mouse model of Burkitt's lymphoma to show that paracrine factors in the tumor microenvironment modulate lymphoma cell survival following the administration of genotoxic chemotherapy. Specifically, IL-6 and Timp-1 are released in the thymus in response to DNA damage, creating a "chemo-resistant niche" that promotes the survival of a minimal residual tumor burden and serves as a reservoir for eventual tumor relapse. Notably, IL-6 is released acutely from thymic endothelial cells in a p38-dependent manner following genotoxic stress, and this acute secretory response precedes the gradual induction of senescence in tumor-associated stromal cells. Thus, conventional chemotherapies can induce tumor regression while simultaneously eliciting stress responses that protect subsets of tumor cells in select anatomical locations from drug action.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These chemoprotective SASP factors include WNT16B, IL-6, and TIMP-1 (tissue inhibitor of metalloproteinases-1).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [134]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even more ironic is the finding that senescent cells, particularly those that senesce in response to DNA-damaging radiation or chemotherapeutic agents, secrete factors that can protect neighboring tumor cells from being killed by those same chemotherapeutic agents (133, 134).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [134]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Antibody against IL-6, gp130 siRNA, or dominant-negative STAT3 enhanced chemo-induced death in lymphoma (Gilbert and Hemann, 2010), as well as colon cancer (Yun et al., 2012)”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Gilbert and Hemann, 2010
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-6 and pY-STAT3 induced by chemotherapy promoted premature senescence in lymphoma cells in a paracrine manner, which maintained a minimal residual number of chemoresistant cells that could lead to relapse.”
From Targeting Janus Kinases and Signal Transducer and Activator of Transcription 3 To Treat Inflammation, Fibrosis, and Cancer: Rationale, Progress, and Caution (2020) · cites this paper as Gilbert and Hemann, 2010
Experimental — accuracy not yet measuredIn the citing paper
“Recent evidence points to tumor microenvironment components as potential participants in the generation of chemoresistance (Denardo et al., 2011; Gilbert and Hemann, 2010; Roodhart et al., 2011; Shaked et al., 2008; Shree et al., 2011).”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Gilbert and Hemann, 2010
In the citing paper
“Recent reports (Denardo et al., 2011; Gilbert and Hemann, 2010) and the present work show that chemotherapy induces a storm of cytokines and chemokines in the tumor microenvironment many of which might be linked to chemoresistance.”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Gilbert and Hemann, 2010
In the citing paper
“The critical role of the microenvironment in tumor progression and response to therapy is being increasingly recognized (Condeelis and Pollard, 2006; Denardo et al., 2011; Gilbert and Hemann, 2010; Shree et al., 2011; Tan et al., 2011).”
From A CXCL1 Paracrine Network Links Cancer Chemoresistance and Metastasis (2012) · cites this paper as Gilbert and Hemann, 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
Cancer stem cells in solid tumours: accumulating evidence and unresolved questions
Visvader, J. E., & Lindeman, G. J. (2008) · Nature reviews. Cancer · doi:10.1038/nrc2499 · Cited by 3,501
Metastasis: from dissemination to organ-specific colonization
Nguyen, D. X., Bos, P. D., & Massagué, J. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2622 · Cited by 2,716
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
Xue, W., Zender, L., Miething, C., Dickins, R. A., Hernando, E., Krizhanovsky, V., Cordon-Cardo, C., & Lowe, S. W. (2007) · Nature · doi:10.1038/nature05529 · Cited by 2,473
Persistent DNA damage signalling triggers senescence-associated inflammatory cytokine secretion
Rodier, F., Coppé, J.-P., Patil, C. K., Hoeijmakers, W. A. M., Muñoz, D. P., Raza, S. R., Freund, A., Campeau, E., Davalos, A. R., & Campisi, J. (2009) · Nature Cell Biology · doi:10.1038/ncb1909 · Cited by 2,232
Grivennikov, S., Karin, E., Terzic, J., Mucida, D., Yu, G.-Y., Vallabhapurapu, S., Scheller, J., Rose-John, S., Cheroutre, H., Eckmann, L., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.01.001 · Cited by 2,155
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway
HEINRICH, P. C., BEHRMANN, I., MÜLLER-NEWEN, G., SCHAPER, F., & GRAEVE, L. (1998) · Biochemical Journal · doi:10.1042/bj3340297 · Cited by 2,130
Oncogene-Induced Senescence Relayed by an Interleukin-Dependent Inflammatory Network
Kuilman, T., Michaloglou, C., Vredeveld, L. C. W., Douma, S., van Doorn, R., Desmet, C. J., Aarden, L. A., Mooi, W. J., & Peeper, D. S. (2008) · Cell · doi:10.1016/j.cell.2008.03.039 · Cited by 2,086
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Flagged first, then by citations
2 of the 42 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Items 401–428 of 428
Ovarian Cancer: Towards Personalizing Ovarian Cancer Treatments Using Patient-Derived Organoids
Volpari, T., Hebner, J., Aiyar, R. S., & Martin, L. A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00080-3
Ding, W., Jiang, G., Long, S., Liao, Y., & Liu, J. (2021) · Research Square · doi:10.21203/rs.3.rs-850455/v1
Cancer Microenvironments as Therapeutic Targets
Kumar, S., & Coussens, L. M. (2014) · Elsevier eBooks · doi:10.1016/b978-0-12-386456-7.01909-2
Cancer biology: Cell neighbours aid cancer relapse
(2010) · Nature · doi:10.1038/468008d
Bevan, C. L., & Constantin, T. A. (2021) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.738340952.793583202
Zhao, H., & Zhu, X. (2013) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.717996667.793474070
Shi, P., Lin, Z., Song, Y., Li, Z., Zeng, M., Luo, L., Cao, Y., & Zhu, X. (2022) · Research Square · doi:10.21203/rs.3.rs-1632846/v1
Therapy-Induced Dormancy and Residual Disease
DiMarco, A. V., Garcia, N. M. G., & Alvarez, J. V. (2022) · Springer eBooks · doi:10.1007/978-3-030-93084-4_10
Cancer and Evolution: An Ancient Relation Explored Recently
Chatterjee, A. (2022) · International Journal of Research and Review · doi:10.52403/ijrr.20220736
DiCenzo, D., Quiaoit, K., Fatima, K., Bhardwaj, D., Sannachi, L., Gangeh, M. J., Naini, A. S., Dasgupta, A., Kolios, M. C., Trudeau, M., et al. (2022) · doi:10.32920/21290982.v1
A senescence-like state is beneficial for ovarian cancer treatmentPreprint
Skulimowski, M., Calvo, L., Cheng, S., Clément, I., Portelance, L., Zhan, Y., Carmona, E., Lafontaine, J., de Ladurantaye, M., Rahimi, K., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.09.30.560300
Zhang, S., Huntington, K. E., Zhou, L., Seyhan, A. A., Kun, B., Carneiro, B. A., Kreiling, J. A., Sedivy, J. M., & El‐Deiry, W. S. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.11.30.569479
Wu, W. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240628ww
YENİ BİR SENOMORFİK İLAÇ ADAYI OLARAK HİDROKLOROTİYAZİD
Demir, Y. D. Ş., & Akgül, S. (2025) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.33483/jfpau.1456430
Surgery for thymic malignancy and nonthymic malignancy incidence: A national longitudinal study
Bouam, S., Bobbio, A., Parlati, L., Tzedakis, S., Daffré, E., Fournel, L., Vénissac, N., Falcoz, P., Mallet, V. O., & Alifano, M. (2025) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2025.05.017
Anthracycline-mediated cardiac dysfunction: An endothelial perspectivePreprint
Markandran, K., Ng, T. J., Tan, E., Clemente, C. K. M., Wang, R. M. Q., Lim, Y. P., Attal, K., Clemente, K. N. M., Wee, H. S.-A., Hammresh, S., et al. (2026) · medRxiv · doi:10.64898/2026.03.02.26347478
Labrousse, G. (2016) · theses.fr (ABES) · doi:10.70675/88a3d193z31f1z4a68z944bz3d7f7316b069
Tissu adipeux et résistance tumorale aux thérapies ciblées
Geneste, A. (2018) · theses.fr (ABES) · doi:10.70675/1521e85cz8c2fz4c73za577z0f6537a4e8de
Champiat, S. (2019) · theses.fr (ABES) · doi:10.70675/e358773dz1898z4feezbb3bzbdee7c7f20a6
An RNA Signature Links Oxidative Stress To Cellular Senescence
Mullani, N. (2019) · theses.fr (ABES) · doi:10.70675/1babf95cz77a0z4561za6cdz6bf733f9f455
Role of chemokines and chemokine receptors in cancer immunology
Babu, D., Natarajan, K., Rajaram, G., Arulsamy, S., & Natarajan, K. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-41551-7.00020-5
Gómez-Escudero, J., Maniati, E., Holdsworth, J., Beattie, G., Hijazi, M., Guelbert, M., Elorbany, S., Cutillas, P. R., Wang, J., Hodivala‐Dilke, K., et al. (2026) · Angiogenesis · doi:10.1007/s10456-026-10063-7 · Cited by 1
Liao, H., Li, H., Song, J. H., Dong, J. H., & Bai, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1878482
Current therapeutic interventions to target cancer stem cells for metastasis
Arora, P., Bhatia, R., Sharma, S., Sharma, A., Chauhan, S. C., Singh, J., & Sharma, A. K. (2026) · International Journal of Clinical Oncology · doi:10.1007/s10147-026-03154-4
Benguigui, M., Lockwood, A., Rajendram, R., Gizer, T., Carter, E., Maniati, E., Cutillas, P. R., Rajeeve, V., Fruhwirth, G. O., Lang, C., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-10046163/v1
Closing the gap in aging science: unlocking the potential of nanoparticles in senescence therapy
Kanbur, E., & Aydin, Ö. F. (2026) · Biogerontology · doi:10.1007/s10522-026-10489-y
Metadata
- Authors
- Gilbert, L. A., & Hemann, M. T.
- Affiliations
- Koch Institute for Integrative Cancer Research At MIT (US)
- Corresponding author
- Hemann, Michael T.
- Venue
- Cell
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 143
- Issue
- 3
- Pages
- 355-366
- ISSN
- 0092-8674 (ISSN-L)
- PMC
- PMC2972353
- OpenAlex
- W2124472585
- Cited by
- 428
- References
- 42
- Citations by year
- 2026: 11 · 2025: 12 · 2024: 12 · 2023: 19 · 2022: 32 · 2021: 35 · 2020: 27 · 2019: 37 · 2018: 33 · 2017: 26 · 2016: 29 · 2015: 25 · 2014: 25 · 2013: 40 · 2012: 40
- FWCI
- 22.74
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1056 d)
- doi.org/10.15223/policy-017 (stm-asf)
- doi.org/10.15223/policy-037 (stm-asf)
- doi.org/10.15223/policy-012 (stm-asf)
- doi.org/10.15223/policy-029 (stm-asf)
- doi.org/10.15223/policy-004 (stm-asf)
- Locations
- Cell (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc)
- Elsevier eBooks
- Funders
- Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology
- National Institutes of Health (5r01ca128803-05)
- Ludwig Center for Molecular Oncology
- National Cancer Institute (R01-CA128803)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Lymphoma Diagnosis and Treatment
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Keywords
- chemoresistance, tumor microenvironment, DNA damage, Burkitt lymphoma, interleukin-6, TIMP-1, thymus, p38 MAPK, genotoxic stress response, senescence, tumor stromal cells, minimal residual disease, tumor recurrence, paracrine signaling
- MeSH terms
- Animals, Burkitt Lymphoma, Cell Survival, DNA Damage, Doxorubicin, Humans, Liver Neoplasms, Thymus Gland, Interleukin-6, Cytokines, Cellular Senescence, Culture Media, Conditioned, Neoplasm, Residual, Cell Culture Techniques, Drug Resistance, Neoplasm, Tissue Inhibitor of Metalloproteinase-1, Paracrine Communication, Endothelial Cells, p38 Mitogen-Activated Protein Kinases, Mice, Janus Kinase 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
